Andrew Jones
2021
In 2021, Andrew Jones earned a total compensation of $564.5K as Chief Financial Officer at NovaBay Pharmaceuticals, a 23% decrease compared to previous year.
Compensation breakdown
| Bonus | $73,500 |
|---|---|
| Salary | $291,667 |
| Stock Awards | $197,500 |
| Other | $1,854 |
| Total | $564,521 |
Jones received $291.7K in salary, accounting for 52% of the total pay in 2021.
Jones also received $73.5K in bonus, $197.5K in stock awards and $1.9K in other compensation.
Rankings
In 2021, Andrew Jones' compensation ranked 10,456th out of 12,415 executives tracked by ExecPay. In other words, Jones earned more than 15.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,456 out of 12,415 | 16th |
Division Manufacturing | 4,629 out of 5,505 | 16th |
Major group Chemicals And Allied Products | 2,074 out of 2,375 | 13th |
Industry group Drugs | 1,839 out of 2,096 | 12th |
Industry Pharmaceutical Preparations | 1,364 out of 1,546 | 12th |
Source: SEC filing on March 30, 2022.
Jones' colleagues
We found two more compensation records of executives who worked with Andrew Jones at NovaBay Pharmaceuticals in 2021.